Jump to main content
Jump to site search

Issue 2, 2014
Previous Article Next Article

Self-assembled, redox-sensitive, H-shaped pegylated methotrexate conjugates with high drug-carrying capability for intracellular drug delivery

Author affiliations

Abstract

A novel prodrug of pegylated methotrexate conjugates (PMCs) with a high drug-carrying capability and a redox sensitive drug release mechanism was reported for intracellular drug delivery. The PMC was structured in a H-shape with four molecules of anticancer drug methotrexate (MTX) linked to both ends of the PEG main chain via disulfide linkers, resulting in the conjugates with a high and constant drug loading efficiency of up to 26 wt%. The amphiphilic property of PMCs enables them to self-assemble into nanoparticles in aqueous solution, while the cleavable disulfide linkers allow the conjugated MTX to exert its therapeutic activity due to the fast cleavage of disulfide linkers when exposed to the intracellular concentration of glutathione (GSH). Cell proliferation assays performed with HepG2 cancer cells confirmed the pharmacological efficacy.

Graphical abstract: Self-assembled, redox-sensitive, H-shaped pegylated methotrexate conjugates with high drug-carrying capability for intracellular drug delivery

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Sep 2013, accepted on 13 Nov 2013 and first published on 21 Nov 2013


Article type: Concise Article
DOI: 10.1039/C3MD00267E
Med. Chem. Commun., 2014,5, 147-152

  •   Request permissions

    Self-assembled, redox-sensitive, H-shaped pegylated methotrexate conjugates with high drug-carrying capability for intracellular drug delivery

    H. Dong, C. Dong, W. Xia, Y. Li and T. Ren, Med. Chem. Commun., 2014, 5, 147
    DOI: 10.1039/C3MD00267E

Search articles by author

Spotlight

Advertisements